In a filing, Gilead Sciences, Inc revealed its Chief Financial Officer Dickinson Andrew D unloaded Company’s shares for reported $0.28 million on Mar 17 ’25. In the deal valued at $110.53 per share,2,500 shares were sold. As a result of this transaction, Dickinson Andrew D now holds 170,674 shares worth roughly $19.08 million.
Then, ANDREW DICKINSON bought 2,500 shares, generating $276,325 in total proceeds.
Before that, Dickinson Andrew D sold 17,929 shares. Gilead Sciences, Inc shares valued at $2,118,696 were divested by the Chief Financial Officer at a price of $118.17 per share. As a result of the transaction, Dickinson Andrew D now holds 169,061 shares, worth roughly $18.9 million.
Oppenheimer reiterated its Gilead Sciences, Inc [GILD] rating to an Outperform in a research note published on March 04, 2025; the price target was $132. A number of analysts have revised their coverage, including Deutsche Bank’s analysts, who increased its forecast for the stock in mid February from “a Hold” to “a Buy”. DZ Bank also remained covering GILD and has increased its forecast on February 13, 2025 with a “Buy” recommendation from previously “Hold” rating. Morgan Stanley revised its rating on January 10, 2025. It rated GILD as “an Overweight” which previously was an “an Equal-weight”.
Price Performance Review of GILD
On Friday, Gilead Sciences, Inc [NASDAQ:GILD] saw its stock jump 0.57% to $111.79. Over the last five days, the stock has gained 4.40%. Gilead Sciences, Inc shares have risen nearly 21.02% since the year began. Nevertheless, the stocks have risen 54.38% over the past one year. While a 52-week high of $119.96 was reached on 03/10/25, a 52-week low of $62.07 was recorded on 01/10/25. SMA at 50 days reached $105.23, while 200 days put it at $87.98.
Levels Of Support And Resistance For GILD Stock
The 24-hour chart illustrates a support level at 110.16, which if violated will result in even more drops to 108.54. On the upside, there is a resistance level at 112.90. A further resistance level may holdings at 114.01. The Relative Strength Index (RSI) on the 14-day chart is 57.43, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.52, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 42.26%. Stochastics %K at 43.34% indicates the stock is a holding.
How much short interest is there in Gilead Sciences, Inc?
A steep rise in short interest was recorded in Gilead Sciences, Inc stocks on 2025-03-14, growing by 1.18 million shares to a total of 22.34 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-14 was 21.16 million shares. There was a rise of 5.27%, which implies that there is a positive sentiment for the stock.
